Amir F. Heshmatpour

This profile gathers the share dealings of Amir F. Heshmatpour across 3 companies, led by Neonc Technologies Holdings, Inc., Bone Biologics Corp and AFH Acquisition IX, Inc. Between 30 August 2017 and 15 September 2026, the trades on record add up to 38 filings.

In open-market terms, that means 23 purchases worth €956k on one side and 4 sales worth €1.8M on the other. Netting one side against the other leaves €817k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants. In 2026 alone, the filings show 13 purchases and no sales.

The median purchase comes to €39k. As a share of market capitalisation, the median purchase stands at 0.050%, based on 9 purchases. Of 23 purchases, 16 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 10 purchases show a median change of -19.1%, with the price up in 10% of them. This is a record of the past, not a forecast.

On 15 September 2026 came the latest disclosure, an open-market purchase for €51k in Neonc Technologies Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.